A new insight of the protective role of estrogens in diabetes

April 5, 2018, University of Geneva
Estrogens influence the entire metabolism at stake, acting both on pancreatic cells producing GLP1 and on so-called L cells the gut harbors, whose main function is also to produce GLP1. Credit: UNIGE

Epidemiological data indicate an explosion of type 2 diabetes cases for women after menopause. What is responsible for that? The surprisingly protective role of oestrogens, highlighted by the fact that a woman undergoing hormone replacement therapy has up to 35 percent less risk of developing type 2 diabetes than a woman without treatment. By elucidating how oestrogen affects two of the hormones involved in glucose homeostasis, glucagon and GLP1, researchers at the University of Geneva (UNIGE), Switzerland, and at the Geneva University Hospitals (HUG) proved the value of oestrogen supplementation from the onset of menopause.

This research, published in JCI Insight, also shows that only one of the three oestrogen receptors seems to be involved in this mechanism. This could ultimately provide much more targeted therapies with a specific molecule that would prevent patients the sometimes embarrassing side effects when treated with a too-powerful hormone regimen.

Diabetes experts know that pre-menopausal women are less likely than men to develop type 2 diabetes. However, after menopause, the trend reverses very clearly, highlighting the protective role of women's sexual hormones and especially oestrogens. But what is their specific on metabolism? This question was answered by the team led by Jacques Philippe, Diabetes specialist at UNIGE Faculty of Medicine and Head of the HUG Department of Endocrinology, Diabetes, Hypertension and Nutrition.

"A number of scientists are working on the effect of oestrogens on pancreatic insulin-producing cells," says Sandra Handgraaf, a researcher at the Faculty of Medicine and the first author of this work. "But its effect on glucagon-producing cells, another hormone regulating blood sugar, had never been explored before. Indeed, if the pancreas secretes insulin, it also secretes glucagon, a hormone with the opposite effect—insulin captures sugar, while glucagon releases it. Diabetes is therefore due to an imbalance between these two hormones controlling the sugar level in the blood."

Pancreatic cells, but also intestinal ones

Oestrogen administration to post-menopausal female mice led the Geneva scientists to identify an increased tolerance to glucose, which is correlated to a lower risk of diabetes. However, if the effect on insulin was expected, the effect on glucagon—and especially on GLP1, an intestinal and pancreatic hormone that increases insulin production—was much less so. These results confirmed the sensitivity to of pancreatic alpha cells, which then secrete less hyperglycemic glucagon, but more GLP1. Also released by the intestine during the absorption of meal, this stimulates the secretion of insulin, inhibits the secretion of glucagon and induces the feeling of satiety. The lack of GLP1 is therefore an essential and little-understood marker of the onset of diabetes. The role played by GLP1 represents a major explanation of the protection of women regarding diabetes onset before menopause.

"This first observation was already interesting," explains Sandra Handgraaf. "But we went a step further. The gut harbours cells called the L cells that are very similar to pancreatic alpha cells and whose main function is precisely to produce GLP1. We also observed a strong increase in the production of GLP1 in the gut cells, thus proving the crucial role of the intestine in the control of carbohydrate balance and the influence of oestrogens on the entire metabolisms at stake." These results were also confirmed on human and tissue samples.

Interesting substitution treatments

Hormonal substitution treatments are often subject to negative publicity, mainly because of the cardiovascular risks associated with them. "It is important to remember that hormonal substitution, when taken at the beginning of menopause and for a few years only, does not cause any particular risk of cardiovascular events," stresses Jacques Philippe. "However, if hormonal treatment is taken more than 10 years after menopause, the cardiovascular risk is effectively increased. In the context of diabetes, an oestrogenic treatment allows to avoid, in all cases, the explosion of female cases. These treatments, well administered, can really add value for women's health."

In their study, the Geneva researchers were also able to dissect the fine cellular mechanisms involved: Of the three oestrogens receptors, only one is mainly involved in this protective effect. It would therefore be possible to develop a molecule that only activates the interesting receptor, with a much more targeted effect. "One could imagine a treatment that, without the side effects of a little too powerful hormonal therapy, would also address men," concludes Sandra Handgraaf.

Explore further: Double advantage of potential new diabetes treatment

More information: JCI Insight, DOI: 10.1172/jci.insight.98569

Related Stories

Double advantage of potential new diabetes treatment

April 19, 2016
Blocking the hormone that raises sugar levels in the blood could increase insulin levels while keeping blood sugar levels down.

Human 'glucostat' identified

March 7, 2018
Pancreatic islets have the overall responsibility for maintaining normal blood glucose levels in the body, according to a new study by researchers at Karolinska Institutet in Sweden and the University of Miami Miller School ...

Study explains how low testosterone raises diabetes risk

April 28, 2016
Doctors have long known that men with low testosterone are at greater risk for developing type 2 diabetes. For the first time, researchers have identified how testosterone helps men regulate blood sugar by triggering key ...

Research elucidates hormone ghrelin's role in blood glucose regulation

May 9, 2017
UT Southwestern research investigating the blood glucose-regulatory actions of the hormone ghrelin may have implications for development of new treatments for diabetes.

What role does the gut play in type 2 diabetes?

August 3, 2017
In the destructive cycle that leads to and perpetuates type 2 diabetes, driven by overeating, excessive blood glucose, defective pancreatic beta cell function, and imbalances in insulin-regulating hormone levels, the gut ...

Recommended for you

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Researchers study abnormal blood glucose levels of discharged patients

December 14, 2018
University of Minnesota Medical School researchers decided to delve into an area where little data currently exists. They wanted to know what happens after these patients with abnormal blood glucose measurements are discharged? ...

Researchers zero in on potential therapeutic target for diabetes, associated diseases

December 14, 2018
A recent study led by researchers in Texas A&M University's department of nutrition and food science shows how a novel regulatory mechanism serves as an important biomarker for the development of diabetes, as well as a potential ...

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

Millions of low-risk people with diabetes may be testing their blood sugar too often

December 10, 2018
For people with Type 2 diabetes, the task of testing their blood sugar with a fingertip prick and a drop of blood on a special strip of paper becomes part of everyday life.

Very low calorie diets trialled by NHS to tackle diabetes

December 7, 2018
Hundreds of thousands of people will receive NHS help to battle obesity and type 2 diabetes under radical action set out by Simon Stevens, Chief Executive of NHS England.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.